BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21070856)

  • 1. Innate immune activation by the viral PAMP poly I:C potentiates pulmonary graft-versus-host disease after allogeneic hematopoietic cell transplant.
    Kinnier CV; Martinu T; Gowdy KM; Nugent JL; Kelly FL; Palmer SM
    Transpl Immunol; 2011 Jan; 24(2):83-93. PubMed ID: 21070856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate immune activation potentiates alloimmune lung disease independent of chemokine (C-X-C motif) receptor 3.
    Martinu T; Kinnier CV; Gowdy KM; Kelly FL; Snyder LD; Jiang D; Foster WM; Garantziotis S; Belperio JA; Noble PW; Palmer SM
    J Heart Lung Transplant; 2011 Jun; 30(6):717-25. PubMed ID: 21444213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective role of T-bet and Th1 cytokines in pulmonary graft-versus-host disease and peribronchiolar fibrosis.
    Gowdy KM; Nugent JL; Martinu T; Potts E; Snyder LD; Foster WM; Palmer SM
    Am J Respir Cell Mol Biol; 2012 Feb; 46(2):249-56. PubMed ID: 21960548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic splenocyte transfer and lipopolysaccharide inhalations induce differential T cell expansion and lung injury: a novel model of pulmonary graft-versus-host disease.
    Martinu T; Kinnier CV; Sun J; Kelly FL; Nelson ME; Garantziotis S; Foster WM; Palmer SM
    PLoS One; 2014; 9(5):e97951. PubMed ID: 24844383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventive azithromycin treatment reduces noninfectious lung injury and acute graft-versus-host disease in a murine model of allogeneic hematopoietic cell transplantation.
    Radhakrishnan SV; Palaniyandi S; Mueller G; Miklos S; Hager M; Spacenko E; Karlsson FJ; Huber E; Kittan NA; Hildebrandt GC
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):30-8. PubMed ID: 25445642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic bone marrow grafts with high levels of CD4(+) CD25(+) FoxP3(+) T cells can lead to engraftment failure.
    Fricke S; Rothe K; Hilger N; Ackermann M; Oelkrug C; Fricke C; Schönfelder U; Niederwieser D; Emmrich F; Sack U
    Cytometry A; 2012 Jun; 81(6):476-88. PubMed ID: 22522779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of C-C motif ligand 2 and C-C motif receptor 2 in murine pulmonary graft-versus-host disease after lipopolysaccharide inhalations.
    Martinu T; Gowdy KM; Nugent JL; Sun J; Kinnier CV; Nelson ME; Lyes MA; Kelly FL; Foster WM; Gunn MD; Palmer SM
    Am J Respir Cell Mol Biol; 2014 Dec; 51(6):810-21. PubMed ID: 24921973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNFAIP8 Deficiency Exacerbates Acute Graft Versus Host Disease in a Murine Model of Allogeneic Hematopoietic Cell Transplantation.
    Kumari R; Palaniyandi S; Strattan E; Huang T; Kohler K; Jabbour N; Dalland J; Du J; Kesler MV; Chen YH; Hildebrandt GC
    Transplantation; 2020 Mar; 104(3):500-510. PubMed ID: 31634333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic pneumonia syndrome in mice after allogeneic bone marrow transplantation.
    Shankar G; Bryson JS; Jennings CD; Morris PE; Cohen DA
    Am J Respir Cell Mol Biol; 1998 Feb; 18(2):235-42. PubMed ID: 9476911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes.
    Ohnuma K; Hatano R; Aune TM; Otsuka H; Iwata S; Dang NH; Yamada T; Morimoto C
    J Immunol; 2015 Apr; 194(8):3697-712. PubMed ID: 25786689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A glucocorticoid amplifies IL-2-induced selective expansion of CD4(+)CD25(+)FOXP3(+) regulatory T cells in vivo and suppresses graft-versus-host disease after allogeneic lymphocyte transplantation.
    Xie Y; Wu M; Song R; Ma J; Shi Y; Qin W; Jin Y
    Acta Biochim Biophys Sin (Shanghai); 2009 Sep; 41(9):781-91. PubMed ID: 19727527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response.
    Jones SC; Murphy GF; Korngold R
    Biol Blood Marrow Transplant; 2003 Apr; 9(4):243-56. PubMed ID: 12720217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAK1 inhibition ameliorates survival from graft-versus-host disease in an allogeneic murine marrow transplantation model.
    Kobayashi A; Kobayashi S; Miyai K; Osawa Y; Horiuchi T; Kato S; Maekawa T; Yamamura T; Watanabe J; Sato K; Tsuda H; Kimura F
    Int J Hematol; 2018 Feb; 107(2):222-229. PubMed ID: 29027124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem Cell Transplantation: An Ancillary Analysis of a Randomized Controlled Trial Comparing Tacrolimus/Sirolimus and Tacrolimus/Methotrexate (Blood and Marrow Transplant Clinical Trials Network/BMT CTN 0402).
    Gooptu M; Kim HT; Howard A; Choi SW; Soiffer RJ; Antin JH; Ritz J; Cutler CS
    Biol Blood Marrow Transplant; 2019 Nov; 25(11):2143-2151. PubMed ID: 31271885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease.
    Pierini A; Colonna L; Alvarez M; Schneidawind D; Nishikii H; Baker J; Pan Y; Florek M; Kim BS; Negrin RS
    J Immunol; 2015 Jul; 195(1):347-55. PubMed ID: 25994967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine cytomegalovirus immediate-early 1 gene expression correlates with increased GVHD after allogeneic hematopoietic cell transplantation in recipients reactivating from latent infection.
    Palaniyandi S; Radhakrishnan SV; Karlsson FJ; Stokes KY; Kittan N; Huber E; Hildebrandt GC
    PLoS One; 2013; 8(4):e61841. PubMed ID: 23596528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of GVHD by regulatory T cells depends on TNF produced by T cells and TNFR2 expressed by regulatory T cells.
    Leclerc M; Naserian S; Pilon C; Thiolat A; Martin GH; Pouchy C; Dominique C; Belkacemi Y; Charlotte F; Maury S; Salomon BL; Cohen JL
    Blood; 2016 Sep; 128(12):1651-9. PubMed ID: 27506541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host reactive donor T cells are associated with lung injury after experimental allogeneic bone marrow transplantation.
    Cooke KR; Krenger W; Hill G; Martin TR; Kobzik L; Brewer J; Simmons R; Crawford JM; van den Brink MR; Ferrara JL
    Blood; 1998 Oct; 92(7):2571-80. PubMed ID: 9746799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.